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Background: Increased risk of osteoporotic bone fractures
represents the adverse event in andropausal men. Due to
diminished calcium absorption in elderly, its supplementa-
tion is used for prevention and treatment of advanced-age
osteoporosis.
Methods: Sixteen-month-old Wistar rats were divided into
sham-operated (SO), orchidectomized (Orx) and Ca2+-
treated orchidectomized (Orx+Ca) groups. Ca2+ (28.55
mg/kg b.w.) was administered intramuscularly for 3 weeks,
while the SO and Orx received vehicle alone. Parathyroid
glands (PTG) were analyzed histomorphometrically, while
the expression of NaPi 2a mRNA from kidneys was deter-
mined by real time PCR. NaPi 2a and PTH1R abundance
was detected immunofluorescently. Serum and urine
parameters were determined biochemically.
Results: The PTG volume was 15% (p<0.05) greater in Orx
rats than in the SO group. In Orx+Ca2+ animals, PTG vol-
ume was decreased by 17% (p<0.05), when compared to
the Orx rats. Orchidectomy led to an increment of serum
PTH of 13% (p<0.05) compared to the SO group, while
Orx+Ca decreased it by 10% (p<0.05) when compared to
Orx animals. The intensity of the NaPi 2a signal was
reduced in Orx rats, in comparison with the SO group.
Orx+Ca2+ treatment increased the abundance of NaPi 2a,
Kratak sadr`aj
Uvod: Pove}an rizik od preloma kostiju, izazvan osteo po -
rozom, uobi~ajen je u andropauzi. Usled smanjene apsorp -
cije kalcijuma kod starijih osoba, on se ~esto koristi u pre-
venciji i tretmanu osteoporoze u poznom dobu.
Metode: Wistar pacovi stari 16 meseci podeljeni su na
la`no operisanu (SO), orhidektomisanu (Orx) i Ca2+ treti-
ranu orhidektomisanu (Orx+Ca) grupu. Ca2+ je aplikovan
intramuskularno u dozi od 28,55 mg/kg telesne mase, dok
su kontrolne grupe SO i Orx primile odgovaraju}i volumen
rastvara~a. Paratireoidne `lezde (PT@) analizirane su histo-
morfometrijski, dok je nivo ekspresije gena za NaPi 2a
odre|en pomo}u PCR metode u realnom vremenu.
Prisustvo NaPi 2a i PTH1R identifikovano je imunofluores-
centnom metodom. Parametri iz seruma i urina odre|eni
su biohemijskim metodama.
Rezultati: Volumen PT@ je pove}an za 15% (p<0,05) kod
Orx pacova u odnosu na SO grupu. Kod Orx+Ca tretiranih
`ivotinja, volumen PT@ je smanjen za 17% (p<0,05) u
pore|enju sa Orx pacovima. Orhidektomija je pove}ala
nivo PTH u serumu za 13% (p<0,05) u odnosu na SO
grupu, dok je nivo ovog hormona kod Orx+Ca pacova
smanjen za 10% (p<0,05) u pore|enju sa Orx `ivotinjama.
Intenzitet NaPi 2a signala je redukovan kod Orx `ivotinja u
odnosu na SO grupu, dok Orx+Ca tretman pove}ava pri -
List of abbreviations: PTH, parathyroid hormone; PTG,
parathyroid glands; CaR, calcium-sensing receptor; PTH1R,
parathyroid hormone receptor type 1; NaPi 2a, sodium-
phosphate cotransporter type 2a; ERK1/2, extracellular-sig-
nal-regulated kinases 1/2. 
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Introduction
Andropause, an age-related syndrome, is in the
first instance characterized by lowered circulating
testosterone, while the luteinizing hormone (LH) and
prolactin levels appear to be normal (1, 2). Also,
dehydroepiandrosterone (DHEA), growth hormone
(GH), thyroxine (T4) and melatonin blood levels are
lowered in andropause, and an increased incidence
of cardiovascular issues, benign and malignant
prostate diseases, as well as osteoporosis are follow-
ing these multihormonal alterations (2, 3). It is gener-
ally known that steroid hormones represent important
regulators of bone resorption and formation (4–6),
but their application in the treatment of age-related
osteoporosis increases the risk of cardiovascular dis-
eases and prostate cancer (7). Besides steroid hor-
mones, calcium (Ca2+) plays a significant role in
bone metabolism in all age groups. Owing to low
dietary Ca2+ intake in elderly (8), accompanied with
low bone mass and increased risk of bone fractures
(9), Ca2+ administered alone or in combination with
vitamin D supplementation is widely used to prevent
and treat osteoporosis (10). However, it has been
observed that Ca2+ supplements are associated with
some cardiovascular adverse events, especially with
myocardial infarction (11).   
The major role in bone metabolism and mineral
homeostasis is attributed to parathyroid hormone
(PTH), the product of parathyroid glands (PTG). The
main regulators of synthesis and secretion of PTH are
low serum Ca2+ concentration, mediated through
calcium-sensing receptor (CaR) (12), and high serum
phosphorus (Pi). Halloran et al. (13) established that
PTG volume and serum PTH level increase in both
rats and humans during ageing. Increased PTH level
contributes to bone loss and also induces phospha-
turia (14, 15), by binding to parathyroid hormone
receptor type 1 (PTH1R) in bone tissue and epithelial
cells of the kidney proximal tubules. Sodium-phos-
phate cotransporter type 2a (NaPi 2a) represents one
of the main regulators of Pi reabsorption from primary
urine in the kidney proximal tubules. Abundance and
activity of NaPi 2a is regulated with a variety of stim-
uli, including dietary phosphate intake, PTH, gluco-
corticoids and steroid hormones (15). 
The positive impact of steroid hormones on the
maintenance of calcium balance reflects on the gas-
trointestinal absorption and renal tubular reabsorp-
tion of calcium (16). Our previous studies have shown
that the orchidectomy-induced lack of steroid hor-
mones caused an enhancement in urinary Ca2+
excretion and decreased serum Ca2+ and Pi concen-
trations (17, 18), along with an increment in Pi uri-
nary wasting, in middle-aged male rats (19). These
chan ges have led to a decrease in the bone tissue
compactness (17, 18), which increases the risk of
bone fragility (9).
Due to the scarce evidence on the influence of
Ca2+ treatment on regulation of Pi homeostasis, the
aim of this study was to examine the effects of Ca2+
application on PTG, functionally related NaPi 2a
cotransporter and PTHR, in kidney tubules of orchi -
de ctomized male rats, as an animal model of the
andropause. 
Materials and Methods 
Experimental design
Middle-aged (16-month-old) Wistar male rats,
bred at the Institute for Biological Research, Bel grade,
Serbia, were maintained under standard laboratory
conditions (22±2˚C, 12–12 h light–dark cycle). Food
and water were available ad libitum.
At the age of 15 months, animals (n=24) were
divided into three groups. The first group of animals
(n=8) was sham-operated (SO), while the other group
(n=16) was bilaterally orchidectomized (Orx), under
ketamine anesthesia (ketamine hydrochloride; Richter
Pharma, Wels, Austria; 15 mg/kg b.w.). After 2 weeks
of recovery, Orx animals were divided into two groups
of eight animals each. One group of Orx rats was
intramuscularly (i.m.) given Ca-glubionate (Novartis,
Switzerland) (Orx+Ca2+; 28.55 mg/kg b.w.) every
compared to the Orx group. In Orx rats, the staining for
PTH1R was stronger when compared to the SO group,
while the Orx+Ca2+ treatment induced reduction of the
PTH1R immunofluorescence, compared to Orx animals.
Orchidec to my increased Pi urinary concentrations by 8%
(p<0.05), in comparison with the SO control, while in the
Orx+Ca2+ group urinary Pi concentration was 5% lower
(p<0.05) than for the Orx rats. 
Conclusions: Our results indicate that Ca2+ administration
reduces the PTH serum level and the presence of PTH1R,
while increased abundance of NaPi 2a cotransporter posi-
tively regulates Pi urine reabsorption in an animal model of
the andropause. 
Keywords: andropause, calcium, NaPi 2a, orchidecto -
mized rats, parathyroid gland, PTH1R
sustvo NaPi 2a, u pore|enju sa Orx grupom. Kod Orx
pacova, obojenost PTH1R je ja~a u odnosu na SO grupu,
dok je Orx+Ca tretman redukovao imunofluorescencu u
pore|enju sa Orx `ivotinjama. Orhidektomija je pove}ala
koncentraciju Pi u urinu za 8% (p<0,05) u pore|enju sa
SO kontrolom, dok je Orx+Ca tretman smanjio koncen-
traciju Pi u urinu za 5% (p<0,05) u odnosu na koncen-
traciju kod Orx pacova.
Zaklju~ak: Prikazani rezultati ukazuju na to da tretman
Ca2+ smanjuje nivo PTH u serumu kao i prisustvo PTH1R,
dok je zastupljenost NaPi 2a kotransportera pove}ana, {to
pozitivno reguli{e reapsorpciju Pi iz urina u animalnom
modelu andropauze.
Klju~ne re~i: andropauza, kalcijum, NaPi 2a, kastrirani
pa covi, paratireoidna `lezda, PTH1R
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day, for 3 weeks. The other Orx group and the SO
group were treated with the vehicle, following the
same regime, and they served as controls. Before sac-
rifice, urine samples were collected for Ca2+ and Pi
analyses. The rats were decapitated 24 h after the last
injection. Blood samples were collected from the trunk
and stored at –80 °C until analysis. All animal proce-
dures were in compliance with the EEC Directive
(86/609/EEC) on the protection of animals used for
experimental and other scientific purposes, and were
approved by the Ethical Committee for the Use of
Laboratory Animals of the Institute for Biological
Research »Sini{a Stankovi}«, University of Belgrade.
Histological and electron microscopy analysis 
Thyroid-parathyroid tissue for the histological
analysis was excised from six animals per group, fixed
in Bouin’s solution for 48 h, embedded in paraplast
and serially cut, using a rotational microtome (Leica,
Germany), at 3 mm thickness. The sections were
stain ed with hematoxylin/eosin and mounted with
DPX (Sigma-Aldrich, Co., USA). 
For the electron microscopy analysis, thyroid-
parathyroid glands were removed from the remaining
two animals per group, and immediately after decap-
itation cut into slices. Tissue slices were immersed in
4% glutaraldehyde solution in 0.1 mol/L phosphate
buffer (PB) (pH 7.4) for 24 h, and postfixed with 1%
OsO4 in the same buffer for 1 h. The samples were
embedded in Araldite and Harderner resin and cut in
ultrathin sections on an LKB ultramicrotome III (type
8802A; Sweden), with a Diatome ultra 45˚ diamond
knife (Diatome, Switzerland). Grids with thin sections
were stained with uranylacetate and leadcitrate, and
examined under a MORGAGNI 268 (FEI Company,
USA) transmission electron microscope.
Stereological measurements 
The volume of PTG was estimated using
Cavalieri’s principle (20) with a newCAST stereologi-
cal software package (VIS–Visiopharm Integrator
System, version 2.12.1.0; Visiopharm; Denmark).
Every 30th section from each of the tissue blocks was
analyzed. The PTG volume (Vptg) was calculated by
the formula: 
where a(p) is the area associated with each sam-
pling point (10956.52 mm2);⎯d is the mean distance
between two consecutively studied sections (90 mm);
n is the number of sections studied for each PTG; and
SPi is the sum of points hitting a given target. The vol-
ume density of chief cells (Vvcc) and interstitium
(blood vessels and connective tissue, Vvi) were deter-
mined for every sampled section.
Immunofluorescent studies
The kidneys were fixed in formalin solution at
room temperature for 48 h, embedded in paraplast,
and sectioned at 3 mm. For the immunofluorescence
staining, sections were deparafinised and dehydrated,
while antigen retrieval was performed in 0.1 mol/L
citrate buffer solution (pH 6.0). Sections were washed
in PBS and pretreated with blocking normal donkey
serum (Dako, Denmark), diluted in PBS (1:10). After
blocking, they were incubated overnight at room tem-
perature, with rabbit anti-rat NaPi 2a antibody
(1:100; kindly donated by Dr Jürg Biber, Institute of
Physiology, University of Zurich, Zurich, Switzerland)
or PTH1R antibody (1:100, Abcam, Cambridge, UK).
After rinsing in PBS, the sections were covered for 2 h
at room temperature with secondary antibody Alexa
Fluor 555 donkey anti-rabbit IgG (1:200; Molecular
Probes, Inc., USA). Finally, they were rinsed five times
in PBS. Sections were cover slipped using Mowiol
4–88 (Sigma-Aldrich, Co., USA) and examined with a
Carl Zeiss AxioVision microscope (Zeiss, Germany). 
RT-PCR
Total RNA was isolated from the rat kidney cor-
tex using TRIzol Reagent (Life Technologies, USA)
according to the manufacturer’s instructions. RNA
was quantified by spectrophotometry, and cDNA was
synthesized using a cDNA Reverse Transcription kit
(Applied Biosystems, USA). PCR amplification of
cDNA was performed in ABI Prism 7000 (Applied
Biosystems) using SYBRGreen (Applied Biosystems)
as follows: 2 minutes at 50 °C for dUTP activation, 10
minutes at 95 °C for initial denaturation of cDNA, fol-
lowed by 40 cycles, each consisting of 15 s of denat-
uration at 95 °C and 60 s at 60 °C for primer anneal-
ing and chain extension. Primer pairs were the
following: NaPi 2a, forward, 5’-GCCACTTCTTCTT
CAACATC-3’; reverse, 5’-CACACGAGGAGGTA-
GAGG- 3’; cyclo A forward 5’-CAAAGTTCCAAA-
GACAGCAGAAAA-3’; reverse, 5’- CCACCCTGGCA-
CATGAAT-3’. The expression level of each gene was
calculated using the formula 2-(Cti-Cta), where Cti is
the cycle threshold value of the gene of interest and
Cta was the cycle threshold value of cyclophilin A as
a reference gene. All of the data were calculated from
triplicate reactions. RNA data are presented as aver-
age relative levels vs. cyclophilin A±SD. 
Biochemical analyses
Serum PTH concentration was measured in
duplicate samples without dilution, using a Rat Intact
PTH ELISA Kit (Immunotopics, Inc., San Clemente,
CA, USA), within a single assay. The intra-assay coef-
n
i=1
⎯Vptg = a(p) ⋅⎯d ⋅ SPi
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ficient of variation (CV) was 2.4%. The lowest concen-
tration of rat intact PTH measurable by this kit is 1.6
pg/mL (the assay sensitivity). Serum concentrations
of Ca2+ and Pi, and urinary concentration of Pi were
determined on a Hitachi 912 analyzer (Roche
Diagnostics GmbH, Mannheim, Germany).
Statistical analysis
STATISTICA® version 6.0 (StatSoft, Inc) was
used for the statistical analysis. All results were
expressed as mean ± SD. Differences between the
groups were assessed by one-way analyses of vari-
ance (ANOVA) followed by Duncan’s multiple range
tests for post hoc comparisons between groups.
Values of p<0.05 were considered statistically signi -
ficant. 
Results
Histological findings in the parathyroid glands
The parathyroid glands (PTG) in all groups were
localized laterally in the thyroid gland lobes. They typ-
ically possessed an oval shape and were surrounded
with a connective tissue capsule. The chief cells were
densely packed in cords or clusters around and along
capillaries, with spherical to oval or elongated nuclei.
PTG in SO rats had an apparent connective tissue
capsule, while the chief cells (white arrows) were sep-
arated with a delicate stroma of connective tissue and
blood vessels (Figure 1A, black arrows). PTG in the
Orx group were larger, with numerous chief cells
(white arrows) and noticeable interstitium, in compar-
ison with SO (Figure 1B, black arrows). After Ca2+
treatment (Orx+Ca), PTGs were smaller, with a more
massive interstitium compared to the glands in Orx
animals (Figure 1C, black arrows). 
Ultrastructural observations in the parathyroid
glands
Ultrastructural analyses of PTG in the SO group
demonstrated compactly arranged chief cells, with
numerous folds and interdigitations of the cell mem-
brane. Rough endoplasmatic reticulum (RER, white
arrows) and the Golgi complex (black arrows) were
Figure 2 Ultrathin sections of PTG chief cells from A) sham-operated (SO), B) orchidectomized (Orx) and C) orchidectomized
rats treated with Ca2+ (Orx+Ca). RER (white arrows), Golgi complex (black arrows) and mitochondria (black arrow head) are
marked as the representative structures. Scale bar – 500 nm.
Figure 1 Sections of PTG from A) sham-operated (SO), B) orchidectomized (Orx) and C) orchidectomized rats treated with Ca2+
(Orx+Ca). Chief cells (white arrows) and interstitium (black arrows) are clearly visible. Hematoxylin-eosin staining, scale bar – 100 mm. 
moderately developed while mitochondria (black
arrow heads) were dispersed throughout the cyto-
plasm. Nuclei were elongated and located near the
apical domain of the cells (Figure 2A). Interdigitations
of the plasma membrane in Orx animals were more
numerous than in the chief cells of SO animals. The
RER (white arrows) and Golgi complex (black arrows)
were more developed than in the SO group, with
abundant mitochondria (black arrow heads) and larg-
er centrally located nuclei (Figure 2B). Ultrastructural
micrographs of chief cells from Orx animals treated
with Ca2+ (Orx+Ca) showed less prominent plasma
membrane interdigitations. The RER (white arrows)
and Golgi complex (black arrows) were poorly repre-
sented with fewer and smaller mitochondria (black
arrow heads), in comparison with the Orx animals
(Figure 2C). 
PTG volume
In SO middle-aged male rats PTG volume was
0.21±0.02 mm3. In Orx rats, PTG volume was 15%
(p<0.05) greater than in the SO group (Figure 3A).
After Ca2+ treatment (Orx+Ca), PTG volume was
decreased by 17% (p<0.05), when compared to the
values of the Orx animals (Figure 3A). In the Orx
group of animals, volume density (Vvcc) of the PTG
chief cells was slightly raised by 2% (p<0.05) in com-
parison with the SO group, while the treatment with
Ca2+ (Orx+Ca) induced a 4% decrease of Vvcc
(p<0.05), when compared to Orx animals (Figure
3B). After Ca2+ treatment (Orx+Ca), the volume
density of interstitium (Vvi) in PTG was increased by
25% (p<0.05), in comparison with the Orx group of
animals (Figure 3B).
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Figure 3 A) The volume of PTG in sham-operated (SO), orchidectomized (Orx) and orchidectomized rats treated with Ca2+
(Orx+Ca). All values are presented as mean±SD; ap<0.05 vs. SO, bp<0.05 vs. Orx. B) Volume density of chief cells (Vvcc) and
interstitium (Vvi) in sham-operated (SO), orchidectomized (Orx) and orchidectomized rats treated with Ca2+ (Orx+Ca). All values
are presented as mean±SD; •p<0.05 vs. SO, *p<0.05 vs. Orx.
Figure 4 Localization of NaPi 2a cotransporter in epithelial cells of proximal tubules. A) In the sham-operated (SO) group of ani-
mals NaPi 2a was strongly labeled in the apical brush border pole of proximal tubule epithelial cells; B) NaPi 2a staining intensi-
ty in the apical domain of proximal tubule cells was decreased after orchidectomy (Orx). C) After Ca2+ treatment (Orx+Ca) the
intensity of NaPi 2a labeling was slightly increased. Paraffin sections, immunofluorescence, scale bar – 10 mm.
Immunofluorescent appearance of NaPi 2a and
PTH1R
Kidney sections of all experimental groups were
immunofluorescently stained with the specific anti-
body for NaPi 2a and PTH1R. Kidney sections of SO
rats showed a strong NaPi 2a signal in the microvilli
of the border brush membrane (BBM, white arrows),
in proximal tubule cells (Figure 4A). In Orx group, the
intensity of the NaPi 2a signal in BBM was reduced,
in comparison with SO animals (Figure 4B, white
arrow). Treatment with Ca2+ (Orx+Ca2+) slightly
increased the abundance of NaPi 2a in the brush bor-
der of the proximal tubules (white arrows), in compar-
ison with the Orx group of animals (Figure 4C). The
immunofluorescent labeling of PTH1R, in the proxi-
mal tubules of SO animals, showed basolateral local-
ization of PTH1R in the epithelial cells of the proximal
kidney tubules (Figure 5A). In Orx animals, the stain-
ing for PTH1R was stronger when compared to SO
animals (Figure 5B), while the treatment with Ca2+
(Orx+Ca2+) induced some reduction of the immuno-
fluorescent signal in the basolateral domain of proxi-
mal tubule epithelial cells (Figure 5C).
RT-PCR
Analysis of the NaPi 2a mRNA level revealed
that Orx decreased NaPi 2a mRNA compared to the
SO group of animals, while Ca2+ administration led
to a slight increase in the NaPi 2a mRNA expression
level, in comparison with Orx animals (Figure 6).
Biochemical findings
Biochemical findings are shown in Table I.
Orchidectomy induced a 13% increase in serum PTH
(p<0.05), when compared to SO animals. After
treatment with Ca2+ (Orx+Ca), serum PTH concen-
tration was 10% lower (p<0.05) than in the Orx
group. In the Orx group, the concentrations of Ca2+
and Pi were decreased by 3% and 4% (p<0.05)
respectively, in comparison with the SO group. In
Orx+Ca animals, serum concentrations of Ca2+ and
Pi were 3% and 10% (p<0.05) higher, respectively,
than in Orx animals. Orchidectomy increased Pi uri-
nary concentrations by 8% (p<0.05), in comparison
with the SO control, while urinary Pi concentration
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Figure 5 Immunofluorescence imaging of PTH1R in epithelial cells of proximal tubules. A) Kidney section of SO animals showed
prevalent basolateral in relation to apical localization of PTH1R often seen in a punctuate pattern. B) Considerably stronger PTH1R
staining was present in orchidectomized rats (Orx). C) After Ca2+ treatment (Orx+Ca) weaker abundance of PTH1R was present.
Paraffin sections, immunofluorescence, scale bar – 10 mm.
Figure 6 Real-time PCR analyses for NaPi 2a mRNA in control (SO), orchidectomised (Orx) and orchidectomized rats treated
with Ca2+ (Orx+Ca); data are presented as relative expression of mRNA.
was 5% (p<0.05) lower after Ca2+ treatment
(Orx+Ca) than in the Orx group. 
Discussion
Increased bone turnover and the risk of osteo-
porotic bone fractures represent the common adverse
events in andropausal men, mainly caused by an age-
related decline in the serum testosterone level. Due to
decreased dietary calcium intake and its diminished
absorption from the small intestine in elderly (8),
accompanied with an increase in PTH concentration
(13), calcium supplementation is widely used for the
prevention and treatment of advanced-age osteoporo-
sis (10). In the present study, we investigated the
effects of chronic Ca2+ treatment on the structure and
function of PTG, NaPi 2a and PTH1R in the proximal
kidney tubules of middle-aged male orchidectomized
rats, as an animal model of the andropause. Pi reab-
sorption in the proximal tubules is dominantly NaPi 2a
mediated, whose downregulation with PTH is realized
through the extracellular-signal-regulated kinases 1/2
(ERK1/2) signaling pathway (21).
In Orx middle-aged rats, the lack of steroid hor-
mones induced a significant increase in PTG volume,
volume density of its chief cells and serum PTH.
Furthermore, the ultrastructural analysis showed
numerous, finger-like cell membrane invaginations in
Orx animals together with well developed RER and
Golgi complex, as well as a large number of mito-
chondria, when compared to SO rats. As suggested
by Coleman and Silberman (22), these ultrastructural
features appear to be reliable indicators of in creased
PTH synthesis. In addition, the observed reduction of
serum Ca2+ concentration after Orx also contributes
to the rise in PTH concentration (19). Furthermore, it
is established that low serum Ca2+ concentration reg-
ulates PTH mRNA stability posttranscriptionally,
through the interactions of RNA-binding protein with
the PTH mRNA (23). Treatment with Ca2+ in our
experimental conditions led to significantly decreased
PTG volume, Vvcc and serum PTH concentration, in
comparison with the Orx animals. However, Vvi was
significantly increased after Ca2+ treatment, when
compared to Orx rats, which further lowers the PTG
chief cells secretory potential. Ultrastructural analysis
of chief cells after Ca2+ treatment revealed less
prominent interdigitations on the chief cells’ mem-
brane, together with poorly developed RER and Golgi
complex, and fewer mitochondria. Inhi bitory effect of
Ca2+ treatment on the histomorphometric and ultra-
structural characteristics of PTG chief cells, together
with the expected increase in Ca2+ serum concentra-
tion we observed, is in line with the previously shown
decreased synthesis and secretion of PTH, mediated
by calcium-sensing receptor (CaR) activation (24, 25). 
The biochemical findings showed a significant
increase in Pi urinary excretion, together with a de -
crease in serum Ca2+ and Pi concentrations after
Orx, which is consistent with our previous results
(17–19). The observed increase in urine Pi concen-
tration after Orx could be a consequence of the
reduced expression of NaPi 2a cotransporter in the
epithelial cells of kidney proximal tubules (19). In
addition, the ob ser ved increase in the immunofluo-
rescent signal of PTH1R in Orx animals‘ epithelial
cells of the kidney proximal tubules could also point
to reduced Pi uptake from primary urine. Namely,
since PTH has a stimulatory effect on PTH1R mRNA
stability (26), an increased presence of PTH1R could
provide the inhibitory effect of PTH on abundance of
NaPi 2a (27, 28). After Ca2+ treatment, the expect-
ed increase in serum Ca2+ occurred, together with a
rise in serum Pi concentration, the latter implying
enhancement of Pi reabsorption rate from the urine.
Treatment with Ca2+ slightly increased NaPi 2a
cotransporter gene expression and its immunofluores-
cent signal on the BBM of epithelial cells of the kid-
ney proximal tubules, when compared to Orx ani-
mals. However, the presence of PTH1R was reduced
after Ca2+ administration, which could be in accor-
dance with the reduction in PTH serum concentration
(26). Additionally, the in crement of serum Ca2+ con-
centration could activate CaR in proximal tubule cells
and specifically attenuate PTH-suppressible Pi
absorption in the epithelial cells of kidney proximal
tubules (29). 
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All values are presented as mean±SD, •p<0.05 vs. SO, *p<0.05 vs. Orx.
SO Orx Orx+Ca
PTH (ng/L) 65.96±3.96 74.57±2.24 • 67.7±5.13 *
Serum Ca2+ (mmol/L) 2.32±0.03 2.26±0.06 • 2.33±0.03 *
Serum Pi (mmol/L) 1.93±0.05 1.89±0.07 • 2.09±0.06 *
Urine Pi (mmol/L) 35.22±0.98 38.12±0.73 • 36.33±0.79 *
Table I Serum and urine parameters in sham-operated (SO), orchidectomized (Orx) and orchidectomized rats treated with Ca2+
(Orx+Ca) group.
Our study showed that Ca2+ administration re -
duced the PTH serum level and the presence of
PTH1R, while the increased abundance of NaPi 2a
cotransporter induced an enhancement of Pi urine
reabsorption in an animal model of the andropause.
These findings suggest that the use of Ca2+ in the
prevention and treatment of andropausal symptoms
implicates some mi ne ral metabolism beneficial
effects, but further studies are needed for the clarifi-
cation of the exact mechanisms of its action.
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